Search for: "TEVA PHARMACEUTICALS USA INC"
Results 21 - 40
of 480
Sorted by Relevance
|
Sort by Date
30 Aug 2020, 10:19 am
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
1 Sep 2015, 9:59 pm
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
23 Nov 2018, 8:03 pm
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
25 Jun 2017, 9:25 pm
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]
16 Sep 2013, 9:59 pm
Teva Pharmaceuticals USA. [read post]
14 Oct 2014, 9:59 pm
By Andrew Williams -- On Wednesday, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
17 Oct 2018, 7:49 pm
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
31 Oct 2011, 5:42 pm
San Diego - Last week, Pfizer announced its victory in a patent infringement battle with Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of Virginia. [read post]
26 Jun 2018, 8:51 pm
Teva Pharmaceuticals USA Inc., Docket No. 17-1229.... [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
31 Mar 2014, 8:47 pm
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]
7 Jun 2018, 4:59 pm
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
13 Oct 2014, 8:46 pm
Teva Pharmaceuticals USA, Inc. et al. v. [read post]
24 Jun 2015, 9:59 pm
Teva Pharmaceuticals USA, Inc. [read post]
26 Jan 2010, 9:59 pm
Teva Pharmaceuticals USA, Inc., Proctor & Gamble Co. v. [read post]
11 Sep 2020, 7:06 am
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
9 Jan 2017, 9:36 am
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
17 Apr 2014, 12:49 pm
Teva Pharmaceuticals USA, Inc., the maker of a widely used drug for treating multiple sclerosis, told the Supreme Court on Thursday that it is willing to put aside promptly up to $500 million to cover marketing losses that generic competitors might have if Teva succeeds in keeping them on the sidelines for months with their lower-priced alternative versions of the drug. [read post]
